A comparison between 1,25-dihydroxy-22-oxavitamin D3 and 1,25-dihydroxyvitamin D3 regarding suppression of parathyroid hormone secretion and calcaemic action

被引：24

作者：

Hirata, M

Endo, K

Katsumata, K

Ichikawa, F

Kubodera, N

Fukagawa, M

机构：

[1] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Shizuoka 4128513, Japan

[2] Kobe Univ, Sch Med, Div Nephrol, Kobe, Hyogo 650, Japan

[3] Kobe Univ, Sch Med, Dialysis Ctr, Kobe, Hyogo 650, Japan

来源：

NEPHROLOGY DIALYSIS TRANSPLANTATION | 2002年 / 17卷

关键词：

calcaemic action; 22-oxacalcitriol; OCT; 1,25(OH)(2)D-3; parathyroid hormone; secondary hyperparathyroidism;

D O I：

10.1093/ndt/17.suppl_10.41

中图分类号：

R3 [基础医学]; R4 [临床医学];

学科分类号：

1001 ; 1002 ; 100602 ;

摘要：

(1)Fuji Gotemba Research Labs, Chugai Pharmaceutical Co., Ltd, Shizuoka, Japan and (2)Kobe University School of Medicine, Division of Nephrology and Dialysis Center, Kobe, Japan.

引用

页码：41 / 45

页数：5

共 15 条

[1] SYNTHETIC ANALOGS OF VITAMIN-D3 WITH AN OXYGEN ATOM IN THE SIDE-CHAIN SKELETON - A TRAIL OF THE DEVELOPMENT OF VITAMIN-D COMPOUNDS WHICH EXHIBIT POTENT DIFFERENTIATION-INDUCING ACTIVITY WITHOUT INDUCING HYPERCALCEMIA [J].

ABE, J ;

MORIKAWA, M ;

MIYAMOTO, K ;

KAIHO, SI ;

FUKUSHIMA, M ;

MIYAURA, C ;

ABE, E ;

SUDA, T ;

NISHII, Y .

FEBS LETTERS, 1987, 226 (01) :58-62

[2] THE NONCALCEMIC ANALOG OF VITAMIN-D, 22-OXACALCITRIOL, SUPPRESSES PARATHYROID-HORMONE SYNTHESIS AND SECRETION [J].

BROWN, AJ ;

RITTER, CR ;

FINCH, JL ;

MORRISSEY, J ;

MARTIN, KJ ;

MURAYAMA, E ;

NISHII, Y ;

SLATOPOLSKY, E .

JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (03) :728-732

[3] CALCITRIOL ORAL PULSE THERAPY IN CHILDREN WITH RENAL OSTEODYSTROPHY [J].

CANO, F ;

DELUCCHI, A ;

WOLFF, E ;

RODRIGUEZ, E ;

FUENTES, A .

PEDIATRIC NEPHROLOGY, 1995, 9 (05) :606-608

[4] 1,25-dihydroxyvitamin D-3 and 22-oxacalcitriol prevent the decrease in vitamin D receptor content in the parathyroid glands of uremic rats [J].

Denda, M ;

Finch, J ;

Brown, AJ ;

Nishii, Y ;

Kubodera, N ;

Slatopolsky, E .

KIDNEY INTERNATIONAL, 1996, 50 (01) :34-39

[5] ON THE MECHANISMS FOR THE SELECTIVE ACTION OF VITAMIN-D ANALOGS [J].

DUSSO, AS ;

NEGREA, L ;

GUNAWARDHANA, S ;

LOPEZHILKER, S ;

FINCH, J ;

MORI, T ;

NISHII, Y ;

SLATOPOLSKY, E ;

BROWN, AJ .

ENDOCRINOLOGY, 1991, 128 (04) :1687-1692

[6]

Fukagawa M, 1997, KIDNEY INT, V52, pS60

[7]

Fukagawa M, 1997, SEMIN SURG ONCOL, V13, P73, DOI 10.1002/(SICI)1098-2388(199703/04)13:2<73::AID-SSU2>3.3.CO

[8]

2-3

[9] THE BINDING-PROPERTIES, WITH BLOOD PROTEINS, AND TISSUE DISTRIBUTION OF 22-OXA-1-ALPHA,25-DIHYDROXYVITAMIN D-3, A NONCALCEMIC ANALOG OF 1-ALPHA,25-DIHYDROXYVITAMIN D-3, IN RATS [J].

KOBAYASHI, T ;

TSUGAWA, N ;

OKANO, T ;

MASUDA, S ;

TAKEUCHI, A ;

KUBODERA, N ;

NISHII, Y .

JOURNAL OF BIOCHEMISTRY, 1994, 115 (03) :373-380

[10] Long-term effects of intravenous calcitriol therapy on the control of secondary hyperparathyroidism [J].

Malberti, F ;

Corradi, B ;

Cosci, P ;

Calliada, F ;

Marcelli, D ;

Imbasciati, E .

AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 28 (05) :704-712

← 1 2 →